Total Payments
$2,893
2024 Payments
$660.50
Companies
13
Transactions
69
Medicare Patients
3,097
Medicare Billing
$231,713
Payment Breakdown by Category
Food & Beverage$2,433 (84.1%)
Education$459.94 (15.9%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,433 | 64 | 84.1% |
| Education | $459.94 | 5 | 15.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $613.11 | 14 | $0 (2024) |
| Janssen Biotech, Inc. | $510.76 | 15 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $337.24 | 3 | $0 (2022) |
| PFIZER INC. | $280.02 | 14 | $0 (2024) |
| GENZYME CORPORATION | $243.37 | 6 | $0 (2024) |
| ABBVIE INC. | $228.32 | 3 | $0 (2024) |
| LEO Pharma Inc. | $196.31 | 8 | $0 (2024) |
| NOVARTIS PHARMACEUTICALS CORPORATION | $121.88 | 1 | $0 (2018) |
| Janssen Scientific Affairs, LLC | $121.75 | 1 | $0 (2018) |
| VYNE Pharmaceuticals Inc. | $119.64 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $660.50 | 18 | Amgen Inc. ($319.49) |
| 2023 | $658.73 | 22 | GENZYME CORPORATION ($172.50) |
| 2022 | $271.49 | 7 | Regeneron Healthcare Solutions, Inc. ($108.32) |
| 2021 | $374.02 | 13 | Janssen Biotech, Inc. ($149.82) |
| 2020 | $103.41 | 1 | Amgen Inc. ($103.41) |
| 2019 | $367.46 | 4 | AbbVie, Inc. ($109.91) |
| 2018 | $457.41 | 4 | Regeneron Healthcare Solutions, Inc. ($123.83) |
All Payment Transactions
69 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $99.00 | General |
| Category: Immunology | ||||||
| 12/11/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $14.68 | General |
| Category: Inflammation | ||||||
| 12/10/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $127.78 | General |
| Category: Inflammation | ||||||
| 11/06/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $6.44 | General |
| Category: Inflammation | ||||||
| 11/04/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $24.94 | General |
| Category: DERMATOLOGY | ||||||
| 10/21/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $13.85 | General |
| Category: IMMUNOLOGY | ||||||
| 10/07/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $24.40 | General |
| Category: DERMATOLOGY | ||||||
| 07/30/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $25.37 | General |
| Category: DERMATOLOGY | ||||||
| 06/11/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $19.47 | General |
| Category: DERMATOLOGY | ||||||
| 06/10/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $13.77 | General |
| Category: DERMATOLOGY | ||||||
| 05/30/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: Inflammation | ||||||
| 04/30/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $27.16 | General |
| Category: DERMATOLOGY | ||||||
| 04/01/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $7.43 | General |
| Category: Inflammation | ||||||
| 02/17/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $17.17 | General |
| Category: DERMATOLOGY | ||||||
| 02/12/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $43.75 | General |
| Category: Immunology | ||||||
| 01/30/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $6.15 | General |
| Category: Inflammation | ||||||
| 01/17/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $32.13 | General |
| Category: DERMATOLOGY | ||||||
| 01/09/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $7.01 | General |
| Category: Inflammation | ||||||
| 11/09/2023 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $3.91 | General |
| Category: DERMATOLOGY | ||||||
| 11/01/2023 | PFIZER INC. | LITFULO (Drug) | Food and Beverage | In-kind items and services | $105.36 | General |
| Category: IMMUNOLOGY | ||||||
| 10/19/2023 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $9.40 | General |
| Category: DERMATOLOGY | ||||||
| 10/17/2023 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $8.32 | General |
| Category: Inflammation | ||||||
| 10/03/2023 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $32.71 | General |
| Category: Immunology | ||||||
| 09/20/2023 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $6.34 | General |
| Category: DERMATOLOGY | ||||||
| 09/12/2023 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $21.42 | General |
| Category: DERMATOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 1,691 | 2,832 | $372,125 | $130,757 |
| 2022 | 14 | 1,176 | 1,921 | $236,037 | $85,583 |
| 2021 | 8 | 230 | 361 | $39,396 | $15,372 |
Total Patients
3,097
Total Services
5,114
Medicare Billing
$231,713
Procedure Codes
43
All Medicare Procedures & Services
43 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 436 | 570 | $98,433 | $36,189 | 36.8% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 159 | 177 | $35,032 | $12,061 | 34.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 254 | 316 | $41,111 | $11,990 | 29.2% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 131 | 141 | $31,225 | $11,522 | 36.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 95 | 120 | $29,280 | $10,457 | 35.7% |
| 13101 | Complicated repair of wound of trunk, 2.6-7.5 cm | Office | 2023 | 23 | 24 | $18,581 | $7,874 | 42.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 106 | 106 | $22,698 | $7,465 | 32.9% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Office | 2023 | 15 | 16 | $13,222 | $5,612 | 42.4% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 200 | 1,034 | $13,458 | $5,478 | 40.7% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 31 | 33 | $10,837 | $4,273 | 39.4% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 56 | 87 | $8,523 | $3,593 | 42.2% |
| 11300 | Shaving of skin growth of body, arms, or legs, 0.5 cm or less | Office | 2023 | 41 | 50 | $9,903 | $3,067 | 31.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 28 | 28 | $8,889 | $2,839 | 31.9% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 26 | 28 | $13,288 | $2,820 | 21.2% |
| 11301 | Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2023 | 14 | 14 | $3,335 | $1,277 | 38.3% |
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2023 | 11 | 11 | $5,954 | $1,262 | 21.2% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 11 | 11 | $2,695 | $1,102 | 40.9% |
| 69100 | Biopsy of ear | Office | 2023 | 12 | 13 | $2,443 | $745.20 | 30.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 16 | 16 | $1,734 | $644.00 | 37.1% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 12 | 13 | $1,437 | $467.00 | 32.5% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 14 | 24 | $48.06 | $19.78 | 41.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 296 | 381 | $67,027 | $26,189 | 39.1% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 150 | 157 | $31,957 | $11,001 | 34.4% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 87 | 101 | $22,666 | $8,742 | 38.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 115 | 115 | $24,978 | $8,190 | 32.8% |
About Dr. Tal Buntinx, MD
Dr. Tal Buntinx, MD is a Dermatology healthcare provider based in Middletown, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/08/2017. The National Provider Identifier (NPI) number assigned to this provider is 1013446590.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Tal Buntinx, MD has received a total of $2,893 in payments from pharmaceutical and medical device companies, with $660.50 received in 2024. These payments were reported across 69 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($2,433).
As a Medicare-enrolled provider, Buntinx has provided services to 3,097 Medicare beneficiaries, totaling 5,114 services with total Medicare billing of $231,713. Data is available for 3 years (2021–2023), covering 43 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Other Specialties Internal Medicine
- Location Middletown, RI
- Active Since 06/08/2017
- Last Updated 07/28/2021
- Taxonomy Code 207N00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1013446590
Products in Payments
- Otezla (Drug) $594.53
- DUPIXENT (Biological) $456.78
- TREMFYA (Drug) $336.40
- Tremfya (Drug) $283.70
- ADBRY (Biological) $196.31
- DUPIXENT DUPILUMAB INJECTION (Biological) $123.83
- COSENTYX (Biological) $121.88
- ZILXI (Drug) $119.64
- SKYRIZI (Biological) $118.41
- Humira (Biological) $109.91
- LITFULO (Drug) $105.36
- EUCRISA (Drug) $90.02
- CIBINQO (Drug) $84.64
- BOTOX COSMETIC (Biological) $80.46
- TALTZ (Drug) $22.99
- VTAMA (Drug) $17.17
- REMICADE (Biological) $12.41
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Middletown
Mr. Salvatore Sciurba, Pa-C, PA-C
Dermatology — Payments: $19,198
Dermatology $19,198
Dr. Victoria Comeau, Do, DO
Dermatology — Payments: $10,212
Dermatology $10,212
Hanna Kim, M.d, M.D
Dermatology — Payments: $6,199
Dermatology $6,199
Dr. Sarah Belden, D.o, D.O
Dermatology — Payments: $3,012
Dermatology $3,012
Jason Michaels, Md, MD
Dermatology — Payments: $2,798
Dermatology $2,798
Antoine Salloum, Md, MD
Dermatology — Payments: $2,687
Dermatology $2,687